Psoriasis Topical Approaches

Size: px
Start display at page:

Download "Psoriasis Topical Approaches"

Transcription

1 Psoriasis Topical Approaches Conflict of Interest Statement Investigator and/or consultant for the following companies which market or are developing products for psoriasis: David M. Pariser, MD Private Practice and Department of Dermatology Eastern Virginia Medical School Norfolk, Virginia Galderma Abbott/AbbVie Eli Lilly Stiefel Pfizer Leo Pharma Amgen Centocor/Janssen Biotech Celgene Merck Bohenger Ingleheim Conflict of Interest Statement I own no patents or equity interest in any companies marketing or developing products for psoriasis I do not do promotional speaking I am not a member of any speakers bureaus If I make any recommendations that are of label I will identify Which patients are candidates for topical therapy? Limited body surface area: 10% 5% 3% Specific locations: Scalp, face, flexural folds, genitalia, palms, soles Inverse psoriasis Hard to treat areas: elbows, knees, lower legs Persistent plaques in anyone receiving systemic or phototherapy The Psoriasis Treatment Toolbox When evaluating a patient with psoriasis Topical Treatments Oral Systemic Agents Methotrexate Cyclosporine Acitretin Other immunosuppressants Apremilast Phototherapy UVB PUVA Excimer Laser Biologic Agents Etanercept Adalimumab Infliximab Ustekinumab Secukinumab Ixekizumab Patients with psoriasis should be considered by the clinician to fall into one of two categories Psoriasis treatable solely with topical agents Psoriasis which will need a systemic approach Traditional systemic, biologic and/ or phototherapy Often combined with each other and with topicals Give up the classification of mild/moderate/severe 1

2 Psoriasis Treatable Topically Psoriasis Requiring a Systemic Approach Systemic therapy needed Don t waste time with topicals alone Limited Surface Area but topical alone just won t do No chance for topicals alone 2

3 Corticosteroids Vitamin D Analogs Calcineurin Inhibitors Retinoids Others: tar, salicylic acid Combinations Let s Talk Topicals Cream Lotion Ointment Gel Foam Spray Tape But first: Vehicles It s all about the base Corticosteroids Most often used topical agent Available in cream, lotion, gel, ointment, foam, spray and tape Are given a potency ranking based on vasoconstrictor assay Higher potency corticosteroids for plaques on scalp, trunk and extremities Lower potency for face, neck and intertriginous areas Adverse effects: hypopigmentation, atrophy, striae, telangiectasia Vitamin D Analogs Calcipotriene May be a first line treatment Often used in combination with corticosteroids Available in cream, ointment as single agent Combination betamethasone calcipotriene product available in ointment and foam Calcineurin Inhibitors tacrolimus and pimecrolimus Commonly used to treat psoriasis on the face, neck, intertriginous areas and genitalia although off label FDA approved to tret atopic dermatitis Available as ointment (tacrolimus) or cream (pimecrolimus) Steroid sparing agent. Retinoids Vitamin A derivative Tazarotene is the only topical retinoid approved for psoriasis Available in cream and gel Reduces epidermal proliferation Major problem is irritation Use together with topical corticosteroid may reduce irritation Pregnancy category X 3

4 4

5 5

PATIENT RESOURCES: PSORIASIS

PATIENT RESOURCES: PSORIASIS PATIENT RESOURCES: PSORIASIS Psoriasis is a persistent skin disorder in which there are red, thickened areas with silvery scales, most often on the scalp, elbows, knees, and lower back. Some cases, of

More information

X-Plain Psoriasis Reference Summary

X-Plain Psoriasis Reference Summary X-Plain Psoriasis Reference Summary Introduction Psoriasis is a long-lasting skin disease that causes the skin to become inflamed. Patches of thick, red skin are covered with silvery scales. It affects

More information

Public Forum on Psoriasis. 2011 National Series

Public Forum on Psoriasis. 2011 National Series Public Forum on Psoriasis 2011 National Series Jerry Tan MD FRCPC Schulich School of Medicine and Dentistry, University of Western Ontario Windsor, Ontario, Canada Presented at Caboto Club, Windsor, April

More information

Psoriasis Treatment Transition Pathway

Psoriasis Treatment Transition Pathway Psoriasis Treatment Transition Pathway A Treatment Support Tool Adapted from Circle Nottingham NHS Treatment Centre Psoriasis Pathway (under consultation) with support from Abbvie Ltd Treatment Pathways

More information

Top 10 Psoriasis Treatment Tips

Top 10 Psoriasis Treatment Tips Top 10 Psoriasis Treatment Tips Steven R. Feldman, MD, PhD Professor of Dermatology, Pathology & Social Sciences Director, Psoriasis Treatment Center Wake Forest University School of Medicine Winston-Salem,

More information

Treatment options a simple guide

Treatment options a simple guide Guide Treatment options a simple guide To decide which treatment is right for you, a good starting point is to know what options you have and to understand the pros and cons of each one. People respond

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis PLAQUE PSORIASIS AND ITS TREATMENTS Learn how vitamin D medications play an important role in managing plaque psoriasis 2 Understanding Plaque Psoriasis WHAT CAUSES PLAQUE PSORIASIS? No one knows exactly

More information

Prescribing advice for the management and treatment of psoriasis

Prescribing advice for the management and treatment of psoriasis Prescribing advice for the management and treatment of psoriasis This guidance contains suggested advice for the management and treatment of patients presenting with psoriasis. This guidance applies to

More information

全 球 银 屑 病 治 疗 药 物 市 场 研 究 报 告 Psoriasis Drugs - A Global Strategic Business Report

全 球 银 屑 病 治 疗 药 物 市 场 研 究 报 告 Psoriasis Drugs - A Global Strategic Business Report 全 球 银 屑 病 治 疗 药 物 市 场 研 究 报 告 Psoriasis Drugs - A Global Strategic Business Report : / :568 :2010-06-12 :3950 / + : : : Psoriasis Drugs 2010-4 This report analyzes the worldwide markets for Psoriasis Drugs

More information

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine Psoriasis Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine Psoriasis Psoriasis is a chronic skin disorder resulting from a polygenic predisposition combined with

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations

More information

Psoriasis Across the Life Course. Disclosure 4/1/2015. Melodie Young, MSN, A/GNP-c, DcNP Modern Research Associates Dallas, TX

Psoriasis Across the Life Course. Disclosure 4/1/2015. Melodie Young, MSN, A/GNP-c, DcNP Modern Research Associates Dallas, TX Psoriasis Across the Life Course Melodie Young, MSN, A/GNP-c, DcNP Modern Research Associates Dallas, TX Disclosure Consultant: AbbVie, Amgen, Celgene, Lilly, Novartis, Speaker s bureau: AbbVie, Celgene,

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies Alan Menter,

More information

Hitchcock Clinic Manchester, NH. Psoriasis. Overview. Psoriasis 3/9/2009. From heartbreak to heart attack. Mark Quitadamo, MD

Hitchcock Clinic Manchester, NH. Psoriasis. Overview. Psoriasis 3/9/2009. From heartbreak to heart attack. Mark Quitadamo, MD Hitchcock Clinic Manchester, NH Psoriasis From heartbreak to heart attack Mark Quitadamo, MD Overview Psoriasis and psoriatic arthritis are common skin and joint disease Psoriasis Unfortunately it is a

More information

Psoriasis - suspected

Psoriasis - suspected Psoriasis - suspected Possible link to alcohol use, depression, other medications History and examination Consider referral to Health Trainers Consider differential diagnoses Is the patient systemically

More information

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 Is Monotherapy Treatment of Etanercept

More information

An overview of. PSORIASIS and PSORIATIC ARTHRITIS.» Diagnosis» Symptoms» Triggers» Treatments

An overview of. PSORIASIS and PSORIATIC ARTHRITIS.» Diagnosis» Symptoms» Triggers» Treatments An overview of PSORIASIS and PSORIATIC ARTHRITIS» Diagnosis» Symptoms» Triggers» Treatments WHAT IS PSORIASIS? PSORIASIS is pronounced sore-eye-ah-sis. It is an autoimmune disease, meaning that certain

More information

2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life

2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life Psoriasis: 2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life 15-25%: moderate-to-severe disease - candidates for systemic therapies - often difficult to manage

More information

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames.

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames. VOLUME 6 NUMBER 6 2000 PSORIASIS National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames.ie SUMMARY The aim of treatment is

More information

CASE REPORTS AND LITERATURE REVIEW OF GENITAL PSORIASIS: SUCCESSFUL THERAPY WITH TACROLIMUS

CASE REPORTS AND LITERATURE REVIEW OF GENITAL PSORIASIS: SUCCESSFUL THERAPY WITH TACROLIMUS CASE REPORTS AND LITERATURE REVIEW OF GENITAL PSORIASIS: SUCCESSFUL THERAPY WITH TACROLIMUS *Marina Talamonti, Marco Galluzzo, Ernesto De Piano, Ludovico M. De Zordo, Martina Scaramella, Sergio Chimenti

More information

Psoriasis. Etiology. Clinical feature. Head to Toe Psoriasis, How to Treat? Precipitating factor 11/19/2012

Psoriasis. Etiology. Clinical feature. Head to Toe Psoriasis, How to Treat? Precipitating factor 11/19/2012 Psoriasis Head to Toe Psoriasis, How to Treat? Charoen Choonhakarn, MD Division of Dermatology, Faculty of Medicine Khon Kaen University Chronic inflammatory skin disease, 1-2% of population Male = female,

More information

Key words: Psoriasis, Calcipotriol, Tazarotene. tazarotene. 16 ( 4 ) tazarotene calcipotriol ( 22 : 23-34, 2004)

Key words: Psoriasis, Calcipotriol, Tazarotene. tazarotene. 16 ( 4 ) tazarotene calcipotriol ( 22 : 23-34, 2004) In the treatment of plaque psoriasis, tazarotene was known to be effective, but its efficacy in a Taiwanese population has not been reported. Our purpose was to compare the efficacy, side effects and the

More information

Laser Therapy for Plaque Psoriasis

Laser Therapy for Plaque Psoriasis Laser Therapy for Plaque Psoriasis Policy Number: Original Effective Date: MM.02.027 12/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/01/2015 Section: Medicine Place(s)

More information

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement A Copy of this page signed by all three parties should be retained in the

More information

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong ORIGINAL ARTICLES Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong Drs. C. W. Fung, L.Y. Chong, C.Y. Leung, C. N. Look, K.K. Lo, K. M. Ho Social Hygiene Service

More information

An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options

An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options Release Date: 01/17/2012 Expiration Date: 01/17/2013 FACULTY: Kathryn Haldiman MS, RN FACULTY AND ACCREDITOR DISCLOSURE

More information

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers Treating psoriasis and psoriatic arthritis A booklet for patients and carers Picture credits Cover Stuart Neville Page 4 Dr P. Marazzi/Science Photo Library CNRI/Science Photo Library CID, ISM/Science

More information

Psoriasis is a skin condition that causes scaly red patches on your skin. There's no cure for psoriasis, but there are treatments that can help.

Psoriasis is a skin condition that causes scaly red patches on your skin. There's no cure for psoriasis, but there are treatments that can help. Patient information from the BMJ Group Psoriasis What is it? What are the symptoms? How is it diagnosed? How common is it? What treatments work? What will happen? Questions to ask Psoriasis If you get

More information

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC Psoriasis and lichen planus Department of Dermatology SRM MCH & RC WHAT IS PSORIASIS Psoriasis is a common, chronic, disfiguring, inflammatory and proliferative condition of the skin; in which both genetic

More information

TOPICAL TREATMENTS. for psoriasis NATIONAL PSORIASIS FOUNDATION. » Over-the-counter products» Combination agents» + more

TOPICAL TREATMENTS. for psoriasis NATIONAL PSORIASIS FOUNDATION. » Over-the-counter products» Combination agents» + more NATIONAL PSORIASIS FOUNDATION TOPICAL TREATMENTS for psoriasis» Topical steroids» Vitamin D derivatives» Vitamin A derivatives» Over-the-counter products» Combination agents» + more Photo illustration

More information

Department of Dermatology, Churchill Hospital PUVA Treatment

Department of Dermatology, Churchill Hospital PUVA Treatment Oxford University Hospitals NHS Trust Department of Dermatology, Churchill Hospital PUVA Treatment information for patients CONTENTS What is PUVA 3 What conditions are treated with PUVA? 3 How is PUVA

More information

Contemporary Treatment Approaches to Acne and Psoriasis

Contemporary Treatment Approaches to Acne and Psoriasis A SUPPLEMENT TO Skin & Allergy News Contemporary Treatment Approaches to Acne and Psoriasis Managing Acne in Adult Women New Developments in Therapy for Acne Vulgaris: A Preview The Role of Oral Retinoid

More information

TOPICAL TREATMENTS FOR PSORIASIS

TOPICAL TREATMENTS FOR PSORIASIS TOPICAL TREATMENTS FOR PSORIASIS What are the aims of this leaflet? Patients with psoriasis are usually treated with preparations that are applied to the skin. This leaflet has been written to help you

More information

Foam: A Unique Delivery Vehicle for Topically Applied Formulations

Foam: A Unique Delivery Vehicle for Topically Applied Formulations : A Unique Delivery Vehicle for Topically Applied Formulations Dov Tamarkin, PhD ix Ltd. Key Words:, Emulsion, Lipophilic Emulsion, Nanoemulsion, Aqueous, Hydroethanolic, Potent-Solvent, Suspension, Ointment,

More information

Drug Treatments in Psoriasis

Drug Treatments in Psoriasis Drug Treatments in Psoriasis Authors: David Gravette, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Morgan Luger, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University;

More information

For more information, please contact the National Psoriasis Foundation at 800-723-9166 or

For more information, please contact the National Psoriasis Foundation at 800-723-9166 or For more information, please contact the National Psoriasis Foundation at 800-723-9166 or www.psoriasis.org. PSORIASIS 101: LEARNING TO LIVE IN THE SKIN YOU RE IN is part of an awareness program to educate

More information

Psoriatic Arthritis www.arthritis.org.nz

Psoriatic Arthritis www.arthritis.org.nz Psoriatic Arthritis www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Psoriatic arthritis usually appears in people between the ages of 30 to 50.

More information

TREATMENTS FOR MODERATE OR SEVERE PSORIASIS

TREATMENTS FOR MODERATE OR SEVERE PSORIASIS TREATMENTS FOR MODERATE OR SEVERE PSORIASIS What are the aims of this leaflet? Patients with psoriasis are usually treated with creams and ointments, which are applied to the skin. These are discussed

More information

INDEX Note: PsA stands for psoriatic arthritis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables. Clinical trials and studies are indexed under the acronym of the

More information

Facial Use of Low Potency Steroids With Anti-microbials and Retinoids

Facial Use of Low Potency Steroids With Anti-microbials and Retinoids Facial Use of Low Potency Steroids With Anti-microbials and Retinoids Steven L. Harlan, MD Medical Director, Dermatology Center, Des Moines, IA Introduction: There have been many reports of topical corticosteroids

More information

Phenotypes and Classification of Psoriasis

Phenotypes and Classification of Psoriasis Rheumatology 2010 Birmingham 21 April 2010 Phenotypes and Classification of Psoriasis Christopher E.M. Griffiths Abbott Centocor Incyte Galderma Janssen-Cilag Leo Pharma Lynxx Novartis Pfizer Schering-Plough

More information

Psoriasis is a chronic inflammatory disease that. A Red, Scaly Rash: How to Recognize and Treat Psoriasis. Psoriasis

Psoriasis is a chronic inflammatory disease that. A Red, Scaly Rash: How to Recognize and Treat Psoriasis. Psoriasis Psoriasis A Red, Scaly Rash: How to Recognize and Treat Psoriasis Case Study and Commentary, Sabrina L. Martin, BA, Tushar S. Dabade, MD, and Steven R. Feldman, MD, PhD Abstract Objective: To review the

More information

Secundum Artem COMPOUNDING FOR PATIENTS WITH PSORIASIS

Secundum Artem COMPOUNDING FOR PATIENTS WITH PSORIASIS VOLUME 9 NUMBER 4 Secundum Artem Current & Practical Compounding Information for the Pharmacist. COMPOUNDING FOR PATIENTS WITH PSORIASIS GOALS AND OBJECTIVES Goal: To provide compounding pharmacists supportive

More information

Drug Therapy Guidelines: Humira (adalimumab)

Drug Therapy Guidelines: Humira (adalimumab) Drug Therapy Guidelines: Humira (adalimumab) Effective Date: 5/1/08 Committee Review Date: 1/6/01, 9/18/01, 1/15/02, 1/7/03, 1/20/04, 1/18/05, 12/7/05, 10/15/06, 7/2/07, 11/5/07, 3/25/08 Policy Statements:

More information

Evolving Issues and New Treatment Approaches to Psoriasis:

Evolving Issues and New Treatment Approaches to Psoriasis: Evolving Issues and New Treatment Approaches to Psoriasis: What the PCP Needs to Know Wednesday, April 8, 2015 2:00 pm 3:15 pm Anaheim, California Accredited Provider Educational Partner This activity

More information

biologics for the treatment of psoriasis

biologics for the treatment of psoriasis How to contact us The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF tel: 08456 760 076 (01604) 251 620 fax: (01604) 251 621 email: mail@psoriasis-association.org.uk www.psoriasis-association.org.uk

More information

Jerry Bagel, MD of Windsor Dermatology Home of the Psoriasis Treatment Center of Central New Jersey

Jerry Bagel, MD of Windsor Dermatology Home of the Psoriasis Treatment Center of Central New Jersey JULY 2012 Jerry Bagel, MD of Windsor Dermatology Home of the Psoriasis Treatment Center of Central New Jersey Restoring Quality of Life for Psoriatic Patients Throughout NJ and Beyond Jerry Bagel, MD of

More information

Common Skin Conditions in Children. Liz Moore and Emma King Dermatology Nurse Consultants

Common Skin Conditions in Children. Liz Moore and Emma King Dermatology Nurse Consultants Common Skin Conditions in Children Liz Moore and Emma King Dermatology Nurse Consultants Diagnosis? Nummular Dermatitis Disc pattern rash (discoid eczema) Clearly demarcated edges Occurs at any age Can

More information

subcutaneous initially every 4 weeks then every 12 weeks Coverage Criteria: Express Scripts, Inc. monograph dated 02/24/2010

subcutaneous initially every 4 weeks then every 12 weeks Coverage Criteria: Express Scripts, Inc. monograph dated 02/24/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Humira (adalimumab subcutaneous injection) Commercial HMO/PPO/CDHP

More information

D.RIGOPOULOS, D.IOANNIDES,* D.KALOGEROMITROS, S.GREGORIOU AND A.KATSAMBAS

D.RIGOPOULOS, D.IOANNIDES,* D.KALOGEROMITROS, S.GREGORIOU AND A.KATSAMBAS British Journal of Dermatology 24; 151: 171 175. DOI: 1.1111/j.1365-2133.24.628.x Therapeutics Pimecrolimus cream 1% vs. betamethasone 17-valerate Æ1% cream in the treatment of seborrhoeic dermatitis.

More information

Psoriasis Agents, Topical Review 01/18/2010

Psoriasis Agents, Topical Review 01/18/2010 Review 01/18/2010 Copyright 2007-2010 by Provider Synergies, L.L.C. All rights reserved. Printed in the United States of America. All rights reserved. No part of this publication may be reproduced or transmitted

More information

CLINICAL BRIEFS. Considerations for the Clinical Assessment of the Patient With Plaque Psoriasis. By Amy Krajacic

CLINICAL BRIEFS. Considerations for the Clinical Assessment of the Patient With Plaque Psoriasis. By Amy Krajacic CLINICAL BRIEFS Considerations for the Clinical Assessment of the Patient With Plaque Psoriasis By Amy Krajacic Senior Medical Editor, Custom Publications MediMedia USA, Yardley, Pa. A review of recently

More information

The prevalence of psoriasis in the

The prevalence of psoriasis in the KELLY M. LUBA, D.O., Phoenix, Arizona DANIEL L. STULBERG, M.D., Rose Family Medical Center, Denver, Colorado Chronic plaque psoriasis, the most common form of psoriasis, is a papulosquamous disease defined

More information

Guideline on the management of psoriasis in South Africa

Guideline on the management of psoriasis in South Africa Guideline on the management of psoriasis in South Africa N Raboobee (Chair of Working Group), J Aboobaker, H F Jordaan, W Sinclair, J M Smith, G Todd, R Weiss, D Whitaker, Working Group of the Dermatological

More information

Understanding your psoriasis and psoriatic arthritis medications URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

Understanding your psoriasis and psoriatic arthritis medications URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited. Understanding your psoriasis and psoriatic arthritis medications URAC All Walgreens specialty pharmacy locations are ACHC and URAC accredited. Table of contents Psoriasis and psoriatic arthritis medications:

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists MEDICAL ASSISTANCE HBOOK `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists A. Prescriptions That Require Prior Authorization All prescriptions for Cytokine and CAM Antagonists must

More information

Product: Tazarotene, cream, 500 micrograms per g (0.05%) and 1.0 mg per g (0.1%), 30 g, Zorac

Product: Tazarotene, cream, 500 micrograms per g (0.05%) and 1.0 mg per g (0.1%), 30 g, Zorac PUBLIC SUMMARY DOCUMENT Product: Tazarotene, cream, 500 micrograms per g (0.05%) and 1.0 mg per g (0.1%), 30 g, Zorac Sponsor: Genepharm Australasia Ltd Date of PBAC Consideration: July 2007 1. Purpose

More information

Psoriasis. Student's Name. Institution. Date of Submission

Psoriasis. Student's Name. Institution. Date of Submission Running head: PSORIASIS Psoriasis Student's Name Institution Date of Submission PSORIASIS 1 Abstract Psoriasis is a non-contagious chronic skin disease that is characterized by inflammatory and multiplying

More information

Draft Guidance on Calcipotriene

Draft Guidance on Calcipotriene Contains Nonbinding Recommendations Draft Guidance on Calcipotriene This draft guidance, once finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does

More information

COMPLETE HOW TO TREAT QUIZZES ONLINE (www.australiandoctor.com.au/cpd) to earn CPD or PDP points.

COMPLETE HOW TO TREAT QUIZZES ONLINE (www.australiandoctor.com.au/cpd) to earn CPD or PDP points. HTT_017 JAN18_13. pdf Page 17 10/ 01/ 13, 2: 32 PM How to Treat PULL-OUT SECTION www.australiandoctor.com.au COMPLETE QUIZZES ONLINE (www.australiandoctor.com.au/cpd) to earn CPD or PDP points. inside

More information

Treating Psoriasis Naturally. Dr. Deborah Ardolf, ND

Treating Psoriasis Naturally. Dr. Deborah Ardolf, ND Treating Psoriasis Naturally by Dr. Deborah Ardolf, ND Psoriasis is an extremely common, noncontagious skin disorder affecting between 2% to 4% of the United States population. Psoriasis affects men and

More information

Scalp Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Scalp Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis 10672 SCALP0913 Scalp Psoriasis 12pp final_layout 1 11/10/2013 18:13 Page 2 Scalp Psoriasis A positive approach to psoriasis and psoriatic arthritis What are the aims of this leaflet? This leaflet has

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy Alan Menter,

More information

Systematic Review of UV-Based Therapy for Psoriasis

Systematic Review of UV-Based Therapy for Psoriasis Am J Clin Dermatol (2013) 14:87 109 DOI 10.1007/s40257-013-0015-y EVIDENCE-BASED REVIEW ARTICLE Systematic Review of UV-Based Therapy for Psoriasis Fahad Almutawa Naif Alnomair Yun Wang Iltefat Hamzavi

More information

Dermatology Online Journal UC Davis

Dermatology Online Journal UC Davis Dermatology Online Journal UC Davis Peer Reviewed Title: Summary of the Dutch S3-Guidelines on the treatment of psoriasis 2011 Journal Issue: Dermatology Online Journal, 20(3) Author: Zweegers, J, Dutch

More information

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION. www.arthritis.org 800-283-7800. Psoriatic Arthritis

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION. www.arthritis.org 800-283-7800. Psoriatic Arthritis Psoriatic Arthritis WHAT IS PSORIATIC ARTHRITIS? Psoriatic (sore-ee-aah-tick) arthritis is a condition that causes pain and swelling in joints and scaly patches on the skin. Psoriatic arthritis occurs

More information

Psoriatic arthritis FACTSHEET

Psoriatic arthritis FACTSHEET 1 What is psoriatic arthritis? Psoriatic arthritis (PsA) is a disease where joints around the body become inflamed and sore. It can make moving about difficult and painful. People who have PsA also have

More information

Characteristics and pattern of childhood psoriasis in Saudi Arabia

Characteristics and pattern of childhood psoriasis in Saudi Arabia Original Article Characteristics and pattern of childhood psoriasis in Saudi Arabia Abdul Manan Bhutto, Abdul Majeed Al-Ajlan, Sami N. Al-Suwaidan Department of Dermatology/Psoriasis Research Chair, King

More information

Lasers that emit short pulses of UV light in

Lasers that emit short pulses of UV light in Handheld roadband UV Phototherapy Module for the Treatment of Patients With Psoriasis and Vitiligo Peter P. Rullan, MD Cosmetic Technique Short pulses of UV light in the 300- to 380-nm wavelength have

More information

Childhood Psoriasis a challenge to all

Childhood Psoriasis a challenge to all Childhood Psoriasis a challenge to all Jayakar Thomas 1 & Parimalam Kumar 2 1 Senior Consultant Dermatologist, Apollo Children s Hospital, Chennai. India 2 Parimalam Kumar Senior Assistant Professor of

More information

PSORIASIS. -Multi factorial. -Papulosquamous disorder. -Genetically determined (few) -Chronic Scaly lesions. -Seasonal variations

PSORIASIS. -Multi factorial. -Papulosquamous disorder. -Genetically determined (few) -Chronic Scaly lesions. -Seasonal variations PSORIASIS -Multi factorial -Papulosquamous disorder -Genetically determined (few) -Chronic Scaly lesions -Seasonal variations -Recurrences & remissions Etiology & Pathogenesis T-cell mediated autoimmune

More information

Cyclosporin A treatment in severe childhood psoriasis

Cyclosporin A treatment in severe childhood psoriasis JEADV ISSN 1468-3083 Blackwell Publishing Ltd REVIEW ARTICLE Cyclosporin A treatment in severe childhood psoriasis TM Pereira,* AP Vieira, JC Fernandes, A Sousa-Basto Department of Dermatology and Venereology,

More information

Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation

Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation Clinical Review & Education Consensus Statement Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation Jeffrey J. Crowley, MD; Jeffrey M. Weinberg, MD; Jashin J. Wu,

More information

Psoriasis: Controlled YOUR GUIDE TO BIOLOGICAL TREATMENTS FOR PLAQUE PSORIASIS

Psoriasis: Controlled YOUR GUIDE TO BIOLOGICAL TREATMENTS FOR PLAQUE PSORIASIS Psoriasis: Controlled YOUR GUIDE TO BIOLOGICAL TREATMENTS FOR PLAQUE PSORIASIS 2 Proudly supported by Disclaimer: Some photographs and models used in this booklet are for illustrative purposes only and

More information

The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the

The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the CONSENSUS STATEMENT Consensus Guidelines for the Management of Plaque Psoriasis Sylvia Hsu, MD; Kim Alexander Papp, MD, PhD; Mark G. Lebwohl, MD; Jerry Bagel, MD; Andrew Blauvelt, MD; Kristina Callis Duffin,

More information

Psoriatic Arthritis. Psoriatic Arthritis 3/05

Psoriatic Arthritis. Psoriatic Arthritis 3/05 Psoriatic Arthritis 3/05 Psoriatic Arthritis Arthritis Ireland, 1 Clanwilliam Square, Grand Canal Quay, Dublin 2 T: (01) 661 8188 F: (01) 661 8261 www.arthritisireland.ie What is in this booklet? This

More information

Dry skin, eczema, psoriasis and flare-ups

Dry skin, eczema, psoriasis and flare-ups Dry skin, eczema, psoriasis and flare-ups Let s feel comfortable in our skin FL4368_1000031525 BTS LFGT Specialist Skin A5LFT 12pp V7.indd 1 21/02/2014 09:58 Some of us live with a dry or sore skin condition.

More information

A t f e t r e r th t is s lec e t c u t re r e t h t e e st s u t den e t t sh s ould b e e a b a le e t o t :

A t f e t r e r th t is s lec e t c u t re r e t h t e e st s u t den e t t sh s ould b e e a b a le e t o t : Dermatopharmacology Prof Werner Sinclair Department of Dermatology University of the Free State Outcomes for this Lecture After this lecture the student should be able to: Name the most important characteristics

More information

Psoriasis: an overview

Psoriasis: an overview 22 September/October 2012 SOUTH AFRICAN RHEUMATOLOGY JOURNAL ARTICLE Psoriasis: an overview Dr WH Fouche Dermatologist in private practice George Introduction The term psoriasis refers to a chronic inflammatory

More information

Treatments for Scalp Psoriasis with Emphasis on Calcipotriol Plus Betamethasone Dipropionate Gel (Xamiol )

Treatments for Scalp Psoriasis with Emphasis on Calcipotriol Plus Betamethasone Dipropionate Gel (Xamiol ) V o l u m e 1 4 N u m b e r 4 M a y 2 0 0 9 I n d e x e d b y t h e U S N a t i o n a l L i b r a r y o f M e d i c i n e a n d P u b M e d Treatments for Scalp Psoriasis with Emphasis on Calcipotriol

More information

Immune Modulating Drugs Prior Authorization Request Form

Immune Modulating Drugs Prior Authorization Request Form Patient: HPHC member ID #: Requesting provider: Phone: Servicing provider: Diagnosis: Contact for questions (name and phone #): Projected start and end date for requested Requesting provider NPI: Fax:

More information

Psoriasis Guideline 2006 Introduction

Psoriasis Guideline 2006 Introduction Psoriasis Guideline 2006 Introduction This guidance for the management of patients with psoriasis is based on a document first produced as a multi-author BAD document in 1996. Since this time the BAD has

More information

DISEASE-MODIFYING ANTIRHEUMATIC DRUG THERAPY FOR RHEUMATOID ARTHRITIS

DISEASE-MODIFYING ANTIRHEUMATIC DRUG THERAPY FOR RHEUMATOID ARTHRITIS DISEASE-MODIFYING ANTIRHEUMATIC DRUG THERAPY FOR RHEUMATOID ARTHRITIS APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE NCQA APPROVED CODES HEDIS

More information

Secukinumab for treating moderate to severe plaque psoriasis

Secukinumab for treating moderate to severe plaque psoriasis Secukinumab for treating moderate to severe plaque psoriasis Produced by Aberdeen HTA Group Authors Ewen Cummins 1 Neil Scott 2 Moira Cruickshank 3 Cynthia Fraser 3 Anthony Ormerod 4 Miriam Brazzelli 3

More information

MANAGEMENT OF PSORIASIS VULGARIS

MANAGEMENT OF PSORIASIS VULGARIS i MANAGEMENT OF PSORIASIS VULGARIS Published by: Malaysia Health Technology Assessment Section (MaHTAS) Medical Development Division, Ministry of Health Malaysia Level 4, Block E1, Precinct 1 Federal

More information

Psoriasis and Sensitive Areas

Psoriasis and Sensitive Areas Psoriasis and Sensitive Areas A positive approach to psoriasis and psoriatic arthritis What are the aims of this leaflet? This leaflet is written to help you understand the most sensitive areas of the

More information

Guideline for the use of Biological Therapies in the Treatment of Psoriasis

Guideline for the use of Biological Therapies in the Treatment of Psoriasis 1 Date of Production: March1 st 2011 Date of 1 st review: July 10 th 2015 Date for next review: March1 st 2018 Local Contact Dermatology Consultant Shanti Ayob Patient group to which this applies: Patients

More information

TOPICAL THERAPY. ADVANTAGES - increased dose of medication to affected area. - reduced systemic side effects and toxicity

TOPICAL THERAPY. ADVANTAGES - increased dose of medication to affected area. - reduced systemic side effects and toxicity TOPICAL THERAPY ADVANTAGES - increased dose of medication to affected area. - reduced systemic side effects and toxicity DISADVANTAGES - takes time - may be greasy or messy - may have different preparations

More information

Helpline No: 0861 30 30 30

Helpline No: 0861 30 30 30 ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 PSORIATIC ARTHRITIS This information leaflet is published by the Arthritis Foundation as part of our

More information

Psoriasis. Medical Bulletin. Introduction. Clinical Features. Pathology and Pathogenesis. Dr. King-man HO

Psoriasis. Medical Bulletin. Introduction. Clinical Features. Pathology and Pathogenesis. Dr. King-man HO Dr. King-man HO MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Glasgow, Edin), Dip Derm (London), Dip GUM (LAS) Consultant Dermatologist, Social Hygiene Service, CHP Specialist in Dermatology and

More information

Atopic dermatitis: A practice parameter update 2012

Atopic dermatitis: A practice parameter update 2012 Practice parameter Atopic dermatitis: A practice parameter update 2012 Authors: Lynda Schneider, MD, Stephen Tilles, MD, Peter Lio, MD, Mark Boguniewicz, MD, Lisa Beck, MD, Jennifer LeBovidge, PhD, and

More information

Dr Noluthando Nematswerani Department of Pharmacology

Dr Noluthando Nematswerani Department of Pharmacology Dr Noluthando Nematswerani Department of Pharmacology They account for 2% of consultations in GP Important to make correct diagnosis Adverse reactions to topical or systemic drugs produce a wide variety

More information